DK362189A - Farmaceutisk praeparat til intravenoes indgift - Google Patents

Farmaceutisk praeparat til intravenoes indgift Download PDF

Info

Publication number
DK362189A
DK362189A DK362189A DK362189A DK362189A DK 362189 A DK362189 A DK 362189A DK 362189 A DK362189 A DK 362189A DK 362189 A DK362189 A DK 362189A DK 362189 A DK362189 A DK 362189A
Authority
DK
Denmark
Prior art keywords
intravenoes
administration
pharmaceutical preparation
pharmaceutical
preparation
Prior art date
Application number
DK362189A
Other languages
English (en)
Other versions
DK175540B1 (da
DK362189D0 (da
Inventor
Erno Orban
Tibor Balogh
Lajos Ila
Gabor Ambrus
Antonia Jekkel
Sandor Elek
Eva Tomori
Lajos Siklosi
Eva Toth Sarudy
Imre Moravcsik
Istvan Elekes
Original Assignee
Biogal Gyogyszergyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogal Gyogyszergyar filed Critical Biogal Gyogyszergyar
Publication of DK362189D0 publication Critical patent/DK362189D0/da
Publication of DK362189A publication Critical patent/DK362189A/da
Application granted granted Critical
Publication of DK175540B1 publication Critical patent/DK175540B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK198903621A 1988-07-21 1989-07-21 Farmaceutisk præparat til intravenös indgift DK175540B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU379688 1988-07-21
HU883796A HU201567B (en) 1988-07-21 1988-07-21 Process for production of intravenous medical compositions containing cyclosphorin

Publications (3)

Publication Number Publication Date
DK362189D0 DK362189D0 (da) 1989-07-21
DK362189A true DK362189A (da) 1990-01-22
DK175540B1 DK175540B1 (da) 2004-11-29

Family

ID=10965544

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198903621A DK175540B1 (da) 1988-07-21 1989-07-21 Farmaceutisk præparat til intravenös indgift

Country Status (26)

Country Link
US (1) US5047396A (da)
JP (1) JPH07116051B2 (da)
KR (1) KR0137674B1 (da)
AR (1) AR243382A1 (da)
AT (1) AT402258B (da)
AU (1) AU614862B2 (da)
BE (1) BE1004323A4 (da)
CA (1) CA1332712C (da)
CH (1) CH679120A5 (da)
DD (1) DD283934A5 (da)
DE (1) DE3924207A1 (da)
DK (1) DK175540B1 (da)
FI (1) FI92556C (da)
FR (1) FR2635265B1 (da)
GB (1) GB2221157B (da)
GR (1) GR1002184B (da)
HU (1) HU201567B (da)
IL (1) IL91069A (da)
IT (1) IT1231434B (da)
LU (1) LU87560A1 (da)
NL (1) NL194578C (da)
NO (1) NO175287C (da)
NZ (1) NZ230036A (da)
PT (1) PT91246B (da)
SE (1) SE509174C2 (da)
ZA (1) ZA895588B (da)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
US6007840A (en) * 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
GB2251186A (en) * 1990-12-04 1992-07-01 Randall Neal Gatz Polypeptide for use in treatment of autoimmune disease
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
GB9113872D0 (en) * 1991-06-27 1991-08-14 Sandoz Ag Improvements in or relating to organic compounds
SG45449A1 (en) 1992-05-13 1998-01-16 Sandoz Ltd Ophthalmic compositions
DK0589843T3 (da) 1992-09-25 2002-04-02 Novartis Ag Cyclosporinholdige farmaceutiske præparater
DE4412201A1 (de) * 1993-04-20 1994-11-10 Rentschler Arzneimittel Neue pharmazeutische Zubereitungen zur oralen Verabreichung enthaltend Cyclosporin
CH686761A5 (de) 1993-05-27 1996-06-28 Sandoz Ag Galenische Formulierungen.
US20020099067A1 (en) * 1993-07-08 2002-07-25 Ulrich Posanski Pharmaceutical compositions for sparingly soluble therapeutic agents
TW406020B (en) * 1993-09-29 2000-09-21 Bristol Myers Squibb Co Stabilized pharmaceutical composition and its method for preparation and stabilizing solvent
DE4340781C3 (de) * 1993-11-30 2000-01-27 Novartis Ag Cyclosporin enthaltende flüssige Zubereitungen und Verfahren zu ihrer Herstellung
KR0146671B1 (ko) * 1994-02-25 1998-08-17 김충환 사이클로스포린-함유 분말 조성물
ES2177652T3 (es) * 1994-11-03 2002-12-16 Novartis Ag Nuevas formas de preparacion de ciclosporina para la aplicacion oral con composicion simple y alta biodisponibilidad, y procedimiento para su obtencion.
US5904935A (en) * 1995-06-07 1999-05-18 Alza Corporation Peptide/protein suspending formulations
MX9702809A (es) * 1995-08-25 1998-02-28 Sangstat Medical Corp Formulaciones orales de ciclosporina.
US5834017A (en) * 1995-08-25 1998-11-10 Sangstat Medical Corporation Oral cyclopsporin formulations
US5827822A (en) * 1996-03-25 1998-10-27 Sangstat Medical Corporation Cyclosporin a formulations as nanoparticles
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
US5766629A (en) * 1995-08-25 1998-06-16 Sangstat Medical Corporation Oral cyclosporin formulations
US20050053594A1 (en) * 1995-11-16 2005-03-10 Dario Alessi RAC-PK as a therapeutic agent or in diagnostics, screening method for agents and process for activating RAC-PK
DE19544507B4 (de) * 1995-11-29 2007-11-15 Novartis Ag Cyclosporin enthaltende Präparate
US5858401A (en) * 1996-01-22 1999-01-12 Sidmak Laboratories, Inc. Pharmaceutical composition for cyclosporines
KR20050084502A (ko) 1997-01-30 2005-08-26 노파르티스 아게 오일을 함유하지 않은 사이클로스포린 ａ 함유 제약 조성물
KR100966245B1 (ko) * 1997-03-12 2010-06-28 아보트 러보러터리즈 사이클로스포린 투여용 친수성 2원 시스템
US6346511B1 (en) 1997-09-08 2002-02-12 Panacea Biotec Limited Pharmaceutical composition comprising cyclosporin
US6187747B1 (en) 1997-09-08 2001-02-13 Panacea Biotech Limited Pharmaceutical composition comprising cyclosporin
US6008191A (en) * 1997-09-08 1999-12-28 Panacea Biotec Limited Pharmaceutical compositions containing cyclosporin
AT408186B (de) * 1998-12-15 2001-09-25 Sanochemia Pharmazeutika Ag Wässerige zubereitung von beta-carotin
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
DE10015814A1 (de) * 2000-03-30 2001-10-11 Max Planck Gesellschaft Arzneimittel zur Stimulierung der Leukopoese, zur Behandlung von Tumor- und Protozoenerkrankungen und Verfahren zu seiner Herstellung
FR2826517B1 (fr) * 2001-06-20 2004-03-12 Somfy Dispositif d'alimentation pour store motorise ou similaire
EP2116228A1 (en) * 2001-10-19 2009-11-11 Isotechnika Inc. Novel cyclosporin analog microemulsion preconcentrates
US6979672B2 (en) 2002-12-20 2005-12-27 Polichem, S.A. Cyclosporin-based pharmaceutical compositions
US20050059583A1 (en) 2003-09-15 2005-03-17 Allergan, Inc. Methods of providing therapeutic effects using cyclosporin components
US7276476B2 (en) * 2005-07-13 2007-10-02 Allergan, Inc. Cyclosporin compositions
US20070015691A1 (en) 2005-07-13 2007-01-18 Allergan, Inc. Cyclosporin compositions
US7202209B2 (en) * 2005-07-13 2007-04-10 Allergan, Inc. Cyclosporin compositions
US7297679B2 (en) 2005-07-13 2007-11-20 Allergan, Inc. Cyclosporin compositions
US20070015693A1 (en) * 2005-07-13 2007-01-18 Allergan, Inc. Cyclosporin compositions
US7288520B2 (en) * 2005-07-13 2007-10-30 Allergan, Inc. Cyclosporin compositions
US7501393B2 (en) 2005-07-27 2009-03-10 Allergan, Inc. Pharmaceutical compositions comprising cyclosporins
US7745400B2 (en) * 2005-10-14 2010-06-29 Gregg Feinerman Prevention and treatment of ocular side effects with a cyclosporin
US9839667B2 (en) 2005-10-14 2017-12-12 Allergan, Inc. Prevention and treatment of ocular side effects with a cyclosporin
GB2451811A (en) 2007-08-09 2009-02-18 Ems Sa Delivery composition for solubilising water-insoluble pharmaceutical active ingredients
JP4815418B2 (ja) * 2007-10-19 2011-11-16 カヤバ工業株式会社 空圧緩衝器
BRPI0918253A2 (pt) * 2008-09-12 2015-12-15 Critical Pharmaceuticals Ltd aperfeicoamento na absorcao de agentes terapeuticos atraves das membranas mucosas ou da pele
FR2948568B1 (fr) * 2009-07-30 2012-08-24 Sanofi Aventis Formulation pharmaceutique
PT2683406T (pt) 2011-03-11 2019-07-08 Beth Israel Deaconess Medical Ct Inc Anticorpos anti-cd40 e utilização dos mesmos
HUE056769T2 (hu) 2015-09-04 2022-03-28 Primatope Therapeutics Inc Humanizált anti-CD40 antitestek és felhasználásuk

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3658M (fr) * 1964-02-18 1965-11-02 Michel Marie Andre Guerbet Composition huileuse pour l'injection intravasculaire.
DE2819094A1 (de) * 1977-05-10 1978-11-23 Sandoz Ag Cyclosporin-derivate, ihre verwendung und herstellung
SE445174B (sv) * 1978-03-07 1986-06-09 Sandoz Ag Farmaceutisk komposition innehallande en cyklosporin och en berarsubstans
CH641356A5 (en) * 1979-02-27 1984-02-29 Sandoz Ag Pharmaceutical compositions containing cyclosporin
AU534955B2 (en) * 1980-01-23 1984-02-23 Sandoz Ag Cyclosporin a to treat lymphoproliferative disorders
DE3339235A1 (de) * 1983-10-28 1985-05-09 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von polyurethanen
DE3339236A1 (de) * 1983-10-28 1985-05-09 Bayer Ag Arzneimittelzubereitung
WO1989002745A1 (fr) * 1987-10-02 1989-04-06 Vsesojuzny Kardiologichesky Nauchny Tsentr Akademi Preparation pharmaceutique de traitement de la sclerose en plaques et de la sclerose laterale amyotrophique
GB8729153D0 (en) * 1987-12-14 1988-01-27 Efamol Ltd Fatty acid compositions
US4943560A (en) * 1988-04-06 1990-07-24 Regents Of The University Of Minnesota Solvent system for chronic vascular infusion of hydrophobic drugs
DE3832362A1 (de) * 1988-09-23 1990-03-29 Sandoz Ag Neue cyclopeptolide, verfahren zu ihrer herstellung und ihre verwendung

Also Published As

Publication number Publication date
NL8901902A (nl) 1990-02-16
DK175540B1 (da) 2004-11-29
SE509174C2 (sv) 1998-12-14
PT91246A (pt) 1990-02-08
ZA895588B (en) 1990-07-25
FI893520L (fi) 1990-01-22
GR1002184B (en) 1996-03-12
US5047396A (en) 1991-09-10
GR890100467A (el) 1990-06-27
DD283934A5 (de) 1990-10-31
GB2221157A (en) 1990-01-31
NO892995D0 (no) 1989-07-21
JPH03115227A (ja) 1991-05-16
AU614862B2 (en) 1991-09-12
NO892995L (no) 1990-01-22
NO175287C (no) 1994-09-28
FI92556C (fi) 1994-12-12
SE8902588D0 (sv) 1989-07-21
FI92556B (fi) 1994-08-31
NO175287B (no) 1994-06-20
DE3924207A1 (de) 1990-01-25
CH679120A5 (da) 1991-12-31
AT402258B (de) 1997-03-25
PT91246B (pt) 1995-05-04
FR2635265B1 (fr) 1995-03-17
AR243382A1 (es) 1993-08-31
KR0137674B1 (ko) 1998-05-15
DE3924207C2 (da) 1992-07-09
DK362189D0 (da) 1989-07-21
LU87560A1 (fr) 1991-02-18
HUT50851A (en) 1990-03-28
GB2221157B (en) 1991-12-18
NL194578C (nl) 2002-08-05
IT1231434B (it) 1991-12-04
FR2635265A1 (fr) 1990-02-16
GB8916679D0 (en) 1989-09-06
KR900001364A (ko) 1990-02-27
NZ230036A (en) 1991-02-26
AU3884589A (en) 1990-02-01
SE8902588L (sv) 1990-01-22
IT8921259A0 (it) 1989-07-21
IL91069A (en) 1993-07-08
NL194578B (nl) 2002-04-02
FI893520A0 (fi) 1989-07-21
ATA176789A (de) 1996-08-15
BE1004323A4 (fr) 1992-11-03
HU201567B (en) 1990-11-28
CA1332712C (en) 1994-10-25
JPH07116051B2 (ja) 1995-12-13

Similar Documents

Publication Publication Date Title
DK362189D0 (da) Farmaceutisk praeparat til intravenoes indgift
DK89090D0 (da) Farmaceutisk praeparat
DK481989A (da) Farmaceutiske formuleringer
DK489189A (da) Farmaceutisk praeparat
DK257485D0 (da) Farmaceutiske praeparater til oral indgift
FI894611A7 (fi) Rakeisia farmaseuttisia valmisteita
ATA154489A (de) Feste pharmazeutische ranitidinpraeparate
DK705488D0 (da) Farmaceutisk praeparat
DK256290A (da) Farmaceutisk praeparat indeholdende deoxyribonucleosider til saarheling
DK79889D0 (da) Flerlagsplaster til transdermal laegemiddeladministration
DK603988D0 (da) Farmaceutisk praeparat
NO892764L (no) Medikamentell administreringsform for droevtyggere.
DK496889D0 (da) Peptidholdigt farmaceutisk praeparat
IT1223343B (it) Formulazioni farmaceutiche per somministrazione transdermica
DK336489D0 (da) Farmaceutisk praeparat
DK298389D0 (da) Farmaceutisk praeparat til topisk anvendelse omfattende et amin-funktionelt medikament
DK139388A (da) Farmaceutisk praeparat
DK276288A (da) Farmaceutisk praeparat
BR9006025A (pt) Preparacao farmaceutica
ATA321188A (de) Pharmazeutische zubereitung
DK37589A (da) Farmaceutisk praeparat for 4-aroylimidazol-2-oner
DK80087A (da) Farmaceutisk praeparat til parenteral indgift
DK138888D0 (da) Farmaceutisk praeparat
DK638889A (da) Farmaceutisk kombinationspraeparat
PT85350A (de) Xylometazolinhaltige pharmazeutische praeparate

Legal Events

Date Code Title Description
PUP Patent expired